LYCOS RETRIEVER 
Requip: Treatment
built 655 days ago
Ropinirole (marketed as Requip®) is a non-ergoline dopamine agonist, manufactured by GlaxoSmithKline. It is used in the treatment of Parkinson's disease, and is ... the only medication in the United States with an FDA-approved indication for the treatment of restless legs syndrome.
Source:
Ropinirole (marketed as Requip®) is a non-ergoline dopamine agonist, manufactured by GlaxoSmithKline. It is used in the treatment of Parkinson's disease, and is ... one of two medications in the United States with an FDA-approved indication for the treatment of restless legs syndrome (the other being Pramipexole).
Source:
ROPINIROLE (Requip™) can help treat Parkinson's disease. Ropinirole helps to improve muscle control and movement difficulties. Ropinirole will not cure Parkinson's disease, but will help to control the symptoms of the disease. Ropinirole tablets may be taken together with other medicines that control symptoms of Parkinson's. Ropinirole is ... used for the treatment of Restless Legs Syndrome. Generic ropinirole tablets are not yet available.
Source:
Requip may cause you to fall asleep during normal daytime activities such as working, talking, eating, or driving. You may fall asleep suddenly, even after feeling alert. Tell your doctor if you have any problems with daytime sleepiness or drowsiness. If you are unsure of how this medicine will affect you, be careful if you drive or do anything that requires you to be awake and alert. FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
Source:
Research Triangle Park, NC – (January 3, 2006) – Data published in the January issue of Mayo Clinic Proceedings show that Requip® (ropinirole HCl) Tablets significantly improve RLS symptoms. The study, entitled TREAT RLS US (T[H]erapy with Ropinirole, Efficacy and Tolerability in Restless Legs Syndrome), is the largest U.S.study to date of the treatment of Restless Legs Syndrome (RLS). The TREAT RLS USresults support previous studies with Requip, the first and only FDA-approved treatment for moderate-to-severe primary RLS.
Source:
MORE ABOUT
Treatment